We Are One Seven LLC raised its holdings in shares of The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 49.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,904 shares of the medical device company’s stock after buying an additional 630 shares during the quarter. We Are One Seven LLC’s holdings in Cooper Companies were worth $798,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of COO. Invesco Ltd. lifted its holdings in shares of Cooper Companies by 35.7% during the third quarter. Invesco Ltd. now owns 1,585,683 shares of the medical device company’s stock worth $655,378,000 after buying an additional 417,077 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Cooper Companies by 53.4% during the third quarter. Bank of New York Mellon Corp now owns 828,234 shares of the medical device company’s stock worth $342,318,000 after buying an additional 288,394 shares during the last quarter. Veritas Asset Management LLP lifted its holdings in shares of Cooper Companies by 12.0% during the fourth quarter. Veritas Asset Management LLP now owns 2,001,678 shares of the medical device company’s stock worth $838,583,000 after buying an additional 214,700 shares during the last quarter. Impax Asset Management Group plc acquired a new position in shares of Cooper Companies during the third quarter worth approximately $84,014,000. Finally, Intermede Investment Partners Ltd lifted its holdings in shares of Cooper Companies by 86.3% during the fourth quarter. Intermede Investment Partners Ltd now owns 341,037 shares of the medical device company’s stock worth $142,874,000 after buying an additional 157,948 shares during the last quarter. Institutional investors own 98.38% of the company’s stock.
COO has been the subject of a number of recent research reports. Needham & Company LLC initiated coverage on Cooper Companies in a research note on Friday, April 8th. They issued a “hold” rating for the company. StockNews.com initiated coverage on Cooper Companies in a research note on Thursday, March 31st. They issued a “hold” rating for the company. Piper Sandler upped their target price on Cooper Companies from $490.00 to $500.00 in a research note on Friday, March 4th. Finally, Stephens upped their target price on Cooper Companies from $430.00 to $500.00 and gave the company an “overweight” rating in a research note on Monday, March 7th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, Cooper Companies has an average rating of “Buy” and a consensus target price of $469.00.
Cooper Companies stock opened at $362.48 on Thursday. The stock has a fifty day moving average price of $402.19 and a two-hundred day moving average price of $403.38. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.02 and a quick ratio of 0.67. The firm has a market capitalization of $17.87 billion, a P/E ratio of 19.23, a P/E/G ratio of 2.30 and a beta of 0.90. The Cooper Companies, Inc. has a 52-week low of $348.42 and a 52-week high of $463.59.
Cooper Companies (NYSE:COO – Get Rating) last announced its earnings results on Thursday, March 3rd. The medical device company reported $3.24 EPS for the quarter, topping the consensus estimate of $3.10 by $0.14. The company had revenue of $787.20 million for the quarter, compared to analysts’ expectations of $739.30 million. Cooper Companies had a return on equity of 9.89% and a net margin of 31.00%. The business’s revenue for the quarter was up 15.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.17 earnings per share. On average, equities research analysts predict that The Cooper Companies, Inc. will post 14.09 EPS for the current fiscal year.
Cooper Companies Company Profile (Get Rating)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
- Get a free copy of the StockNews.com research report on Cooper Companies (COO)
- World Wresting Entertainment Stock is Hulking Up
- High-Yield Weyco Group Returns To Reasonable Levels
- MarketBeat Podcast: Alternative Investing Strategies Despite Market Volatility
- Limelight Networks Stock is a Speculative Turnaround Opportunity
- The Selloff In SiteOne Landscape Supply Is Overextended
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.